NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Haemonetics Lands Non-Exclusive Deal with Major Plasma Collector CSL

Haemonetics enters a non-exclusive supply deal with CSL Plasma for NexSys PCS devices with Persona PLUS technology and disposables in the U.S.

Haemonetics Lands Non-Exclusive Deal with Major Plasma Collector CSL
Photo by Aman Chaturvedi on Unsplash
Already have an account? Sign in.
08/18/2026 · 9:05 AM
HAE
/ Don’t stop at just one post.

Related↓

Haemonetics Shares Rise as CSL Plans Full U.S. Plasma Device Switch by 2027
10/08/2026 · 7:57 AM

Haemonetics Shares Rise as CSL Plans Full U.S. Plasma Device Switch by 2027

CSL now expects to switch all current U.S. plasma centers to Haemonetics devices by the end of 2027. Guidance is unchanged.

/ Subscriber only
/ Read more

Feed↓

Tilray Posts Record Revenue, but Cannabis Weakness and a Miss Sink the Stock
10/08/2026 · 9:19 AM

Tilray Posts Record Revenue, but Cannabis Weakness and a Miss Sink the Stock

Record Q1 revenue of $257.1M rose 23% but missed consensus. Cannabis weakness and no guidance raise weighed on the stock.

/ Subscriber only
GlobalFoundries and TSMC Agree on $2 Billion Plan for U.S. Silicon Interposers for AI Packaging
Featured/ 10/08/2026 · 8:43 AM

GlobalFoundries and TSMC Agree on $2 Billion Plan for U.S. Silicon Interposers for AI Packaging

GFS will make silicon interposers for TSMC’s CoWoS packaging in Malta, N.Y., under a multi-year $2B deal, with volume ramp in early 2028.

/ Subscriber only
Viatris to Buy Pacira BioSciences for $1.65 Billion, Adding Non-Opioid Pain Drugs
Featured/ 10/08/2026 · 8:25 AM

Viatris to Buy Pacira BioSciences for $1.65 Billion, Adding Non-Opioid Pain Drugs

Pacira shareholders get $36.50 a share, about 45% above the prior close. The acquisition covers two patent-protected U.S. pain medicines.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI